Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Cheng, Kuoyuan"" wg kryterium: Autor


Wyświetlanie 1-17 z 17
Tytuł:
Author Correction: A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing
Autorzy:
Sinha, SanjuAff1, Aff2, Aff3
Barbosa, Karina
Cheng, KuoyuanAff1, Aff3
Leiserson, Mark D. M.
Jain, Prashant
Deshpande, Anagha
Wilson, III, David M.
Ryan, Bríd M.
Luo, Ji
Ronai, Ze’ev A.
Lee, Joo SangAff7, Aff8
Deshpande, Aniruddha J.Aff4, IDs41467022304755_cor12
Ruppin, EytanAff1, IDs41467022304755_cor13
Pokaż więcej
Źródło:
Nature Communications. 13(1)
Czasopismo naukowe
Tytuł:
A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing
Autorzy:
Sinha, SanjuAff1, Aff2, Aff3
Barbosa, Karina
Cheng, KuoyuanAff1, Aff3
Leiserson, Mark D. M.
Jain, Prashant
Deshpande, Anagha
Wilson, III, David M.
Ryan, Bríd M.
Luo, Ji
Ronai, Ze’ev A.
Lee, Joo SangAff7, Aff8
Deshpande, Aniruddha J.Aff4, IDs41467021267886_cor12
Ruppin, EytanAff1, IDs41467021267886_cor13
Pokaż więcej
Źródło:
Nature Communications. 12(1)
Czasopismo naukowe
Tytuł:
Genome-scale metabolic modeling reveals SARS-CoV-2-induced metabolic changes and antiviral targets.
Autorzy:
Cheng K; Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.; Biological Sciences Graduate Program (BISI), University of Maryland, College Park, MD, USA.
Martin-Sancho L; Immunity and Pathogenesis Program, Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Pal LR; Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.
Pu Y; Immunity and Pathogenesis Program, Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Riva L; Immunity and Pathogenesis Program, Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Yin X; Immunity and Pathogenesis Program, Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.; State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China.
Sinha S; Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.; Biological Sciences Graduate Program (BISI), University of Maryland, College Park, MD, USA.
Nair NU; Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.
Chanda SK; Immunity and Pathogenesis Program, Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
Ruppin E; Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.; Department of Computer Science, University of Maryland, College Park, MD, USA.
Pokaż więcej
Źródło:
Molecular systems biology [Mol Syst Biol] 2021 Nov; Vol. 17 (11), pp. e10260.
Typ publikacji:
Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Pandemics*
Adenosine Monophosphate/*analogs & derivatives
Alanine/*analogs & derivatives
Antiviral Agents/*therapeutic use
COVID-19/*metabolism
Metabolic Networks and Pathways/*genetics
SARS-CoV-2/*physiology
Adenosine Monophosphate/therapeutic use ; Alanine/therapeutic use ; Animals ; COVID-19/virology ; Caco-2 Cells ; Chlorocebus aethiops ; Datasets as Topic ; Drug Development ; Drug Repositioning ; Host-Pathogen Interactions ; Humans ; RNA, Small Interfering ; Sequence Analysis, RNA ; Vero Cells ; COVID-19 Drug Treatment
Czasopismo naukowe
Tytuł:
In vitro and in vivo identification of clinically approved drugs that modify ACE2 expression.
Autorzy:
Sinha S; Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.; Center for Bioinformatics and Computational Biology, University of Maryland, College Park, MD, USA.
Cheng K; Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.; Center for Bioinformatics and Computational Biology, University of Maryland, College Park, MD, USA.
Schäffer AA; Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.
Aldape K; Laboratory of Pathology, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.
Schiff E; Department of Obstetrics, Gynecology and Reproductive Sciences, Chaim Sheba Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Ramat Gan, Tel-Aviv, Israel.
Ruppin E; Cancer Data Science Laboratory (CDSL), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, USA.
Pokaż więcej
Źródło:
Molecular systems biology [Mol Syst Biol] 2020 Jul; Vol. 16 (7), pp. e9628.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Angiotensin Receptor Antagonists/*pharmacology
Angiotensin-Converting Enzyme Inhibitors/*pharmacology
Coronavirus Infections/*drug therapy
Pneumonia, Viral/*drug therapy
A549 Cells ; Angiotensin-Converting Enzyme 2 ; Betacoronavirus ; Bleomycin/pharmacology ; COVID-19 ; Dexamethasone/pharmacology ; Drug Design ; Drug Evaluation, Preclinical ; Erlotinib Hydrochloride/pharmacology ; Fluphenazine/pharmacology ; HEK293 Cells ; Humans ; Kidney/drug effects ; Lung/drug effects ; MCF-7 Cells ; Pandemics ; Peptidyl-Dipeptidase A ; SARS-CoV-2 ; Systems Biology ; Up-Regulation ; Vemurafenib/pharmacology ; COVID-19 Drug Treatment
Czasopismo naukowe
Tytuł:
Combinatorial Detection of Conserved Alteration Patterns for Identifying Cancer Subnetworks.
Autorzy:
Hodzic E; Laboratory for Advanced Genome Analysis, Vancouver Prostate Centre, 2660 Oak St, Vancouver, BC, V6H 3Z6, Canada.; School of Computing Science, Simon Fraser University, 8888 University Dr, Burnaby, BC, V5A 1S6, Canada.
Shrestha R; Laboratory for Advanced Genome Analysis, Vancouver Prostate Centre, 2660 Oak St, Vancouver, BC, V6H 3Z6, Canada.; Department of Urologic Sciences, University of British Columbia, 2775 Laurel St, Vancouver, BC, V5Z 1M9, Canada.
Zhu K; Department of Computer Science, Indiana University Bloomington, 700 N. Woodlawn Ave, Bloomington, IN, 47408, USA.
Cheng K; Center for Bioinformatics and Computational Biology, University of Maryland, 8125 Paint Branch Dr, College Park, MD, 20742, USA.
Collins CC; Laboratory for Advanced Genome Analysis, Vancouver Prostate Centre, 2660 Oak St, Vancouver, BC, V6H 3Z6, Canada.; Department of Urologic Sciences, University of British Columbia, 2775 Laurel St, Vancouver, BC, V5Z 1M9, Canada.
Cenk Sahinalp S; Laboratory for Advanced Genome Analysis, Vancouver Prostate Centre, 2660 Oak St, Vancouver, BC, V6H 3Z6, Canada.; Department of Computer Science, Indiana University Bloomington, 700 N. Woodlawn Ave, Bloomington, IN, 47408, USA.
Pokaż więcej
Źródło:
GigaScience [Gigascience] 2019 Apr 01; Vol. 8 (4).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Computational Biology*/methods
Gene Expression Profiling*/methods
Gene Regulatory Networks*
Transcriptome*
Neoplasms/*genetics
Algorithms ; Biomarkers, Tumor ; Databases, Genetic ; Genomics/methods ; Humans ; Neoplasms/diagnosis ; Neoplasms/metabolism ; Neoplasms/mortality ; Prognosis ; Protein Interaction Mapping ; Protein Interaction Maps
Czasopismo naukowe
Tytuł:
Genome-wide prediction of synthetic rescue mediators of resistance to targeted and immunotherapy.
Autorzy:
Sahu AD; Department of Biostatistics and Computational Biology, Harvard School of Public Health, Boston, MA, USA .; Department of Medicine and Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; University of Maryland Institute of Advanced Computer Science (UMIACS), University of Maryland, College Park, MD, USA.
S Lee J; University of Maryland Institute of Advanced Computer Science (UMIACS), University of Maryland, College Park, MD, USA.; Cancer Data Science Lab, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Wang Z; Department of Pharmacology & Moores Cancer Center, University of California, San Diego La Jolla, CA, USA.
Zhang G; Molecular and Cellular Oncogenesis Program and Melanoma Research Center, The Wistar Institute, Philadelphia, PA, USA.; Department of Neurosurgery and The Preston Robert Tisch Brain Tumor Center, Duke University, Durham, NC, USA.
Iglesias-Bartolome R; National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Tian T; New Jersey Institute of Technology, Newark, NJ, USA.
Wei Z; New Jersey Institute of Technology, Newark, NJ, USA.
Miao B; Department of Medicine and Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, MA, USA.
Nair NU; University of Maryland Institute of Advanced Computer Science (UMIACS), University of Maryland, College Park, MD, USA.; Cancer Data Science Lab, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Ponomarova O; University of Massachusetts Medical School, Worcester, MA, USA.
Friedman AA; Department of Medicine and Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, MA, USA.
Amzallag A; Department of Medicine and Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, MA, USA.
Moll T; Department of Medicine and Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, MA, USA.
Kasumova G; Department of Medicine and Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, MA, USA.
Greninger P; Department of Medicine and Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, MA, USA.
Egan RK; Department of Medicine and Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, MA, USA.
Damon LJ; Department of Medicine and Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, MA, USA.
Frederick DT; Department of Medicine and Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, MA, USA.
Jerby-Arnon L; Schools of Computer Science & Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Wagner A; Department of Electrical Engineering and Computer Science, the Center for Computational Biology, University of California, Berkeley, CA, USA.
Cheng K; University of Maryland Institute of Advanced Computer Science (UMIACS), University of Maryland, College Park, MD, USA.
Park SG; Department of Biostatistics and Computational Biology, Harvard School of Public Health, Boston, MA, USA.
Robinson W; University of Maryland Institute of Advanced Computer Science (UMIACS), University of Maryland, College Park, MD, USA.
Gardner K; Cancer Data Science Lab, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Boland G; Department of Medicine and Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, MA, USA.
Hannenhalli S; University of Maryland Institute of Advanced Computer Science (UMIACS), University of Maryland, College Park, MD, USA.
Herlyn M; Molecular and Cellular Oncogenesis Program and Melanoma Research Center, The Wistar Institute, Philadelphia, PA, USA.
Benes C; Department of Medicine and Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, MA, USA.
Flaherty K; Department of Medicine and Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, MA, USA.
Luo J; National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Gutkind JS; Department of Pharmacology & Moores Cancer Center, University of California, San Diego La Jolla, CA, USA.
Ruppin E; University of Maryland Institute of Advanced Computer Science (UMIACS), University of Maryland, College Park, MD, USA .; Cancer Data Science Lab, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Schools of Computer Science & Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Pokaż więcej
Źródło:
Molecular systems biology [Mol Syst Biol] 2019 Mar 11; Vol. 15 (3), pp. e8323. Date of Electronic Publication: 2019 Mar 11.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Computational Biology*
Drug Synergism*
Drug Resistance, Neoplasm/*genetics
Melanoma/*genetics
Female ; Gene Expression Profiling ; Humans ; Immunotherapy ; Male ; Melanoma/drug therapy ; Molecular Targeted Therapy ; Synthetic Lethal Mutations
Czasopismo naukowe
    Wyświetlanie 1-17 z 17

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies